Surgery Partners (SGRY)
Nasdaq Market Closed
Surgery Partners, Inc. is a healthcare services company focused on outpatient surgical care. The company operates an integrated network of ambulatory surgery centers, surgical hospitals, anesthesia services, and related physician practices, giving it exposure to the continuing shift of many procedures away from traditional inpatient hospital settings.
Its business is organized around surgical facilities that provide care in specialties such as orthopedics, ophthalmology, gastroenterology, pain management, and other procedure-based areas. These facilities generate revenue by delivering healthcare services to patients, with payments coming from commercial insurers, government programs, and patients, depending on coverage and procedure type. The company’s model is built around working closely with physicians while offering facilities that can perform appropriate surgeries in a lower-cost and more convenient outpatient environment.
Surgery Partners benefits from healthcare trends that favour site-of-care migration, as advances in anesthesia, surgical technique, and post-operative management allow more procedures to be performed outside acute-care hospitals. Payers and patients often have incentives to use outpatient settings when clinical quality and safety standards can be maintained at lower overall cost.
The company operates in a highly regulated industry where reimbursement rates, payer mix, labour availability, physician relationships, and facility utilization are central performance drivers. Its scale and integrated operating platform are important differentiators, as outpatient surgical networks require clinical governance, compliance systems, scheduling efficiency, and partnerships with specialists. For investors, Surgery Partners represents a listed healthcare services business tied to demand for elective and non-emergency procedures, the economics of ambulatory surgery centers, and broader changes in how surgical care is delivered in the United States.
Last updated
- Market Cap
- 1.8B
- P/E
- —
- P/FCF
- 8.66
- P/S
- 0.54
- Enterprise Value
- 5.33B
- Sector
- Health Care
- Industry
- General Medical and Surgical Hospitals
- Address
- 340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
Ambulatory Surgical Centers Market to Reach Over US$ 142.6 Billion by 2033 Driven by Rising Outpatient Surgeries, Favorable Reimbursement, and Cost-Efficient Care Models | Astute Analytica
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board
Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details
After-hours movers: Netflix, Intuitive Surgical, and more By Investing.com - Investing.com Canada
Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock?
Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
DocGo Inc. (DCGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Earnings Preview: Surgery Partners (SGRY) Q1 Earnings Expected to Decline
Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details
SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?
Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering
Surgery Partners, Inc. Announces New Senior Notes Offering
Surgery Partners (SGRY) Upgraded to Buy: What Does It Mean for the Stock?
Wall Street Analysts Believe Surgery Partners (SGRY) Could Rally 39.04%: Here's is How to Trade
Company News for Feb 27, 2024
The Zacks Analyst Blog Highlights Microsoft, Amazon.com, Surgery Partners, Nvidia and Occidental Petroleum
Warren Buffett's Annual Letter: Key Insights for Investors
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.8B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 5.33B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.07
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.54
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 8.18
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.59
- EPS
- -0.58
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 12.31%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 8.66
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 6.43
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 208M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -4.51%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -0.95%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.2
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.86
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.69
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.31
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 1.59M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 13.77
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 810.9M | 885M | 821.5M | 826.2M | 776M |
| Gross profit | 810.9M | 885M | 821.5M | 826.2M | 776M |
| Operating income | 66M | 113.7M | 117.4M | 103.2M | 62.7M |
| EBITDA | 122.6M | 193.4M | 174.6M | 161.6M | 125.9M |
| Net income | -35.9M | -15M | -22.7M | -2.5M | -37.7M |
| Basic EPS | -0.28 | -0.11 | -0.18 | -0.02 | -0.3 |
| Diluted EPS | -0.28 | -0.11 | -0.18 | -0.02 | -0.3 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 8.04B | 8.12B | 7.95B | 7.95B | 7.95B |
| Total liabilities | 4.56B | 4.59B | 4.39B | 4.38B | 4.36B |
| Total equity | 3.1B | 3.13B | 3.14B | 3.16B | 3.16B |
| Cash & equivalents | 182.3M | 239.9M | 203.4M | 250.1M | 229.3M |
| Current assets | 1.08B | 1.15B | 1.1B | 1.11B | 1.07B |
| Current liabilities | 581.7M | 615.5M | 586M | 573.3M | 569.4M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 11.7M | 103.4M | 83.6M | 81.3M | 6M |
| Investing cash flow | -13.4M | -126.1M | -46.2M | 2.1M | -76.4M |
| Financing cash flow | -55.9M | 59.2M | -84.1M | -62.6M | 30.2M |
| Change in cash | -57.6M | 36.5M | -46.7M | 20.8M | -40.2M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G/A — Surgery Partners, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Surgery Partners, Inc. | View Filing | |
| edgar index | 8-K — Surgery Partners, Inc. | View Filing | |
| edgar index | 10-Q — Surgery Partners, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Surgery Partners, Inc. | View Filing | |
| edgar index | ARS — Surgery Partners, Inc. | View Filing | |
| edgar index | DEFA14A — Surgery Partners, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Evans Jason Eric | View Filing | |
| form 4 | Form 4 — Doherty David T | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Brittenham Marissa | View Filing | |
| form 4 | Form 4 — Burkhalter Danielle | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Baldock Jennifer | View Filing | |
| edgar index | 3 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| form 3 | Form 3 — Dean Lloyd H | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Brittenham Marissa | View Filing | |
| form 4 | Form 4 — Webb William Trenton | View Filing | |
| form 4 | Form 4 — Burkhalter Danielle | View Filing | |
| form 4 | Form 4 — Baldock Jennifer | View Filing | |
| form 4 | Form 4 — Doherty David T | View Filing | |
| form 4 | Form 4 — Evans Jason Eric | View Filing | |
| edgar index | 144 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Oppenheimer Justin Robert | View Filing | |
| form 4 | Form 4 — Brittenham Marissa | View Filing | |
| form 4 | Form 4 — Brittenham Marissa | View Filing | |
| form 4 | Form 4 — Brittenham Marissa | View Filing | |
| form 4 | Form 4 — Webb William Trenton | View Filing | |
| form 4 | Form 4 — Webb William Trenton | View Filing | |
| form 4 | Form 4 — Webb William Trenton | View Filing | |
| form 4 | Form 4 — Burkhalter Danielle | View Filing | |
| form 4 | Form 4 — Burkhalter Danielle | View Filing | |
| form 4 | Form 4 — Burkhalter Danielle | View Filing | |
| form 4 | Form 4 — Baldock Jennifer | View Filing | |
| form 4 | Form 4 — Baldock Jennifer | View Filing | |
| form 4 | Form 4 — Baldock Jennifer | View Filing | |
| form 4 | Form 4 — Doherty David T | View Filing | |
| form 4 | Form 4 — Doherty David T | View Filing | |
| form 4 | Form 4 — Doherty David T | View Filing | |
| form 4 | Form 4 — Evans Jason Eric | View Filing | |
| form 4 | Form 4 — Evans Jason Eric | View Filing | |
| edgar index | 8-K — Surgery Partners, Inc. | View Filing | |
| edgar index | 10-K — Surgery Partners, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — Surgery Partners, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Surgery Partners, Inc. | View Filing | |
| edgar index | 4 — Surgery Partners, Inc. | View Filing | |
| form 4 | Form 4 — Oppenheimer Justin Robert | View Filing |